Exelixis, Inc. (EXEL): Price and Financial Metrics
EXEL Price/Volume Stats
| Current price | $36.98 | 52-week high | $40.26 |
| Prev. close | $36.17 | 52-week low | $20.14 |
| Day low | $36.23 | Volume | 2,648,700 |
| Day high | $37.29 | Avg. volume | 2,619,929 |
| 50-day MA | $37.02 | Dividend yield | N/A |
| 200-day MA | $32.45 | Market Cap | 10.19B |
EXEL Stock Price Chart Interactive Chart >
Exelixis, Inc. (EXEL) Company Bio
Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.
EXEL Price Returns
| 1-mo | 4.73% |
| 3-mo | 12.74% |
| 6-mo | 5.51% |
| 1-year | 73.86% |
| 3-year | 84.16% |
| 5-year | 49.38% |
| YTD | 11.05% |
| 2024 | 38.81% |
| 2023 | 49.56% |
| 2022 | -12.25% |
| 2021 | -8.92% |
| 2020 | 13.90% |
Continue Researching EXEL
Here are a few links from around the web to help you further your research on Exelixis Inc's stock as an investment opportunity:Exelixis Inc (EXEL) Stock Price | Nasdaq
Exelixis Inc (EXEL) Stock Quote, History and News - Yahoo Finance
Exelixis Inc (EXEL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...